Cannabinoids and the expanded endocannabinoid system in neurological disorders
Anecdotal evidence that cannabis preparations have medical benefits together with the
discovery of the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol (THC) initiated …
discovery of the psychotropic plant cannabinoid Δ9-tetrahydrocannabinol (THC) initiated …
The endocannabinoid system: a potential target for the treatment of various diseases
H Lowe, N Toyang, B Steele, J Bryant… - International journal of …, 2021 - mdpi.com
The Endocannabinoid System (ECS) is primarily responsible for maintaining homeostasis, a
balance in internal environment (temperature, mood, and immune system) and energy input …
balance in internal environment (temperature, mood, and immune system) and energy input …
Phytocannabinoids: origins and biosynthesis
T Gülck, BL Møller - Trends in plant science, 2020 - cell.com
Phytocannabinoids are bioactive natural products found in some flowering plants, liverworts,
and fungi that can be beneficial for the treatment of human ailments such as pain, anxiety …
and fungi that can be beneficial for the treatment of human ailments such as pain, anxiety …
CDKL5 deficiency disorder: clinical features, diagnosis, and management
CDKL5 deficiency disorder (CDD) was first identified as a cause of human disease in 2004.
Although initially considered a variant of Rett syndrome, CDD is now recognised as an …
Although initially considered a variant of Rett syndrome, CDD is now recognised as an …
Use of cannabidiol in the treatment of epilepsy: efficacy and security in clinical trials
S Silvestro, S Mammana, E Cavalli, P Bramanti… - Molecules, 2019 - mdpi.com
Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from
Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest …
Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest …
Epilepsy and cannabidiol: a guide to treatment
Epilepsy and cannabidiol: a guide to treatment | Cairn.info Cairn.info, Matières à réflexion
Cairn.info, Matières à réflexion Aucune suggestion trouvée Compte personnel Adresse email …
Cairn.info, Matières à réflexion Aucune suggestion trouvée Compte personnel Adresse email …
Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure …
OBJECTIVE To assess the effect of oral cannabidiol (CBD) administration in addition to
conventional antiepileptic treatment on seizure frequency in dogs with idiopathic epilepsy …
conventional antiepileptic treatment on seizure frequency in dogs with idiopathic epilepsy …
Cyclin-dependent kinase-like 5 deficiency disorder: clinical review
Abstract Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a
developmental encephalopathy caused by pathogenic variants in the gene CDKL5. This …
developmental encephalopathy caused by pathogenic variants in the gene CDKL5. This …
[HTML][HTML] Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access …
LC Laux, EM Bebin, D Checketts, M Chez, R Flamini… - Epilepsy research, 2019 - Elsevier
Background Since 2014, patients with severe treatment-resistant epilepsies (TREs) have
been receiving add-on cannabidiol (CBD) in an ongoing, expanded access program (EAP) …
been receiving add-on cannabidiol (CBD) in an ongoing, expanded access program (EAP) …
Pharmacological and therapeutic properties of cannabidiol for epilepsy
V Franco, E Perucca - Drugs, 2019 - Springer
Cannabidiol (CBD) is a major active component of the Cannabis plant, which, unlike
tetrahydrocannabinol (THC), is devoid of euphoria-inducing properties. During the last 10 …
tetrahydrocannabinol (THC), is devoid of euphoria-inducing properties. During the last 10 …